The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
The acceptance comes after a study done by the American Diabetes Association in June found that inhaled insulin is safe and ...
The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.
Dermatologist tells you why using untested, unregulated products bought on e-commerce platforms can lead to kidney, skin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback